ING VARIABLE ANNUITIES PROFILE AND PROSPECTUS SUPPLEMENT DATED MAY 22, 2000 to the Prospectuses dated May 1, 2001for the Deferred Combination Variable and Fixed Annuity Contracts ("GOLDENSELECT PREMIUM PLUS/R/ PROSPECTUS," "GOLDENSELECT PREMIUM PLUS GALAXY VIP/R/ PROSPECTUS," "GOLDENSELECT ACCESS/R/ PROSPECTUS," "GOLDENSELECT DVA PLUS/R/ PROSPECTUS," "GOLDENSELECT VALUE/R/ PROSPECTUS," "GOLDENSELECT ESII/R/ PROSPECTUS," "GOLDENSELECT DVA PROSPECTUS," "GOLDENSELECT DVA SERIES 100 PROSPECTUS" "GOLDENSELECT ACCESS/R/ ONE PROSPECTUS," and the "GOLDENSELECT/R/ LANDMARK PROSPECTUS"), issued by Golden American Life Insurance Company, Prospectuses dated May 1, 2001for the Deferred Combination Variable and Fixed Annuity Contracts ("GOLDENSELECT DVA PLUS/R/ PROSPECTUS" and "GOLDENSELECT DVA PLUS/R/ GALAXY VIP PROSPECTUS"), issued by First Golden American Life Insurance Company of New York, and to the Prospectus dated May 1, 2001, for Individual Flexible Premium Deferred Variable Annuity Contracts (the "EQUI-SELECT PROSPECTUS") issued by Equitable Life Insurance Company of Iowa Effective May 5, 2001, ING Pilgrim Investments, LLC, began directly managing the Pilgrim VIT Global Brand Names Fund (the "Fund") series of the Pilgrim Variable Insurance Trust under its existing Investment Management Agreement. ING Investment Management Advisors' B.V. no longer serves as Sub-Adviser of the Fund. Effective May 9, 2001, the Board of Trustees of Pilgrim Variable Insurance Trust approved a change in the name of the Fund to "Pilgrim VIT Worldwide Growth Fund," and the Fund's investment strategy to the following: Under normal market conditions, the Fund invests at least 65% of its net assets in equity securities of issuers located in at least three countries, one of which may be the U.S. The Fund generally invests at least 75% of its total assets in common and preferred stocks, warrants and convertible securities. The Fund may invest in companies located in countries with emerging securities markets when the portfolio managers believe they present attractive investment opportunities. THIS SUPPLEMENT SHOULD BE RETAINED WITH YOUR PROFILE AND PROSPECTUS. 110072 05/22/01